How Can Technology Enhance the Use of Biospecimens in Cancer Research?
Advances in technology have significantly enhanced the use of biospecimens in cancer research. High-throughput sequencing and other genomic technologies allow for comprehensive analysis of genetic material, revealing mutations and other alterations that drive cancer. Proteomics and metabolomics technologies enable the study of proteins and metabolites, providing a deeper understanding of cancer biology. These technological advancements facilitate the discovery of new biomarkers and therapeutic targets.
